FTC Loses Bid to Block Pay-For-Delay Drug Settlements

The FTC on Wednesday lost its latest attempt to thwart deals to delay the production of cheaper, generic drugs that brand-drug companies strike with their competitors.
Thomson Reuters News & Insight